Private Advisor Group’s Bionano Genomics BNGO Stock Holding History

Private Advisor Group’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17	Closed	-$11.6K	–	2028
2023 Q1	$11.6K	Sell	17 -1	-6%	-$888	﹤0.01%	1943
2022 Q4	$15	Hold	18	–	–	﹤0.01%	1650
2022 Q3	$20K	Sell	18 -2	-10%	-$2.64K	﹤0.01%	1874
2022 Q2	$17K	Buy	+20	New	+$20.6K	﹤0.01%	2079
2022 Q1	–	Sell	-21	Closed	-$38K	–	2109
2021 Q4	$38K	Hold	21	–	–	﹤0.01%	2085
2021 Q3	$68K	Sell	21 -6	-22%	-$21K	﹤0.01%	1973
2021 Q2	$119K	Sell	27 -10	-27%	-$39.5K	﹤0.01%	1890
2021 Q1	$177K	Buy	37 +5	+16%	+$28.2K	﹤0.01%	1755
2020 Q4	$59K	Buy	32 +4	+14%	+$1.5K	﹤0.01%	1721
2020 Q3	$11K	Buy	28 +6	+27%	+$2.33K	﹤0.01%	1544
2020 Q2	$7K	Buy	+22	New	+$5.53K	﹤0.01%	3065

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Advisor Group's BNGO Position: Q2 2023 in Review

Private Advisor Group sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 17 shares — an estimated $11.6K sold.

Private Advisor Group first reported a position in BNGO in Q2 2020 and held it in 11 quarters. The position peaked at $177K in Q1 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

Private Advisor Group reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
Private Advisor Group sold 17 Bionano Genomics shares in Q2 2023, an estimated $11.6K.
Private Advisor Group first reported a position in Bionano Genomics in Q2 2020 and held it in 11 quarters.
Private Advisor Group's Bionano Genomics position peaked at $177K in Q1 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.